Immune gamma globulin (Kamada)

N/A

Report date: 2025/11/26 20:00:44

Base Information

Drug NameImmune gamma globulin (Kamada)
Drug Alias NameKamada Anti-SARS-CoV-2
ClassificationBiologics > Protein drugs > Immunoglobulin
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Pneumonia, Viral
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesKamada Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKamada Ltd
Active IndicationsN/A
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)Pneumonia, Viral

Other Information

ATC CodeN/A
Related LinksN/A